Results 141 to 150 of about 4,102 (209)

RNA editing: an emerging frontier in cancer therapy - explorations, opportunities, and challenges. [PDF]

Int J Surg
Chen J, Sun Q, Gong N, Du Z, Zhao Z, Ding D, Zhang H, Yan Q, Yuan S, Jiang S.   +9 more
europepmc   +1 more source

ADARs have effects beyond RNA editing [PDF]

, 2009
Heale, Bret S E, Keegan, Liam P, O'Connell, Mary A   +2 more
core   +1 more source

Age-Related Changes in Matrix Metalloproteinase-9 Expression in Spinal Motor Neurons of Normal Mice. [PDF]

Cureus
Yamazaki J, Hideyama T, Teramoto S, Kato H, Aizawa H, Kwak S, Terashi H.   +6 more
europepmc   +1 more source

Deaminase Modulation Driving a New Era in Drug Development. [PDF]

Int J Mol Sci
Lindley RA.
europepmc   +1 more source

Molecular Context of ADAR-Mediated Editing of Coding RNA in Colorectal and Lung Cancers. [PDF]

Int J Mol Sci
Modestov A, Luppov D, Gaziev I, Golushko N, Zakharova G, Zolotovskaia M, Poddubskaya E, Seryakov A, Prassolov V, Sekacheva M, Buzdin A.   +10 more
europepmc   +1 more source

Identification of ADAR1i-124: The first effective A-to-I RNA editing inhibitor with promising cancer therapeutic potential. [PDF]

iScience
Minakuchi M, Zhang H, Cassel J, Shiromoto Y, Villanueva J, Skordalakes E, Salvino JM, Li Q, Nishikura K.   +8 more
europepmc   +1 more source

Deciphering the mechanistic roles of ADARs in cancer pathogenesis, tumor immune evasion, and drug resistance. [PDF]

Front Immunol
Wang X, Yin F, He Y, Qiao Y, Yan Y, Ma J.   +5 more
europepmc   +1 more source

Unlocking the benefits of aerobic exercise for MAFLD: a comprehensive mechanistic analysis. [PDF]

J Transl Med
Zhang W, Hu Y, Zou F, Ding L, Jiang M.
europepmc   +1 more source

ADAR1: a central regulator of dsRNA sensing in host-virus interactions. [PDF]

Front Immunol
Liu C, Choi Y.
europepmc   +1 more source

ADAR1 editing is necessary for only a small subset of cytosolic dsRNAs to evade MDA5-mediated autoimmunity. [PDF]

Nat Genet
Sun T, Li Q, Geisinger JM, Hu SB, Fan B, Su S, Tsui W, Guo H, Ma J, Li JB.   +9 more
europepmc   +1 more source